J
Jaap W. Deckers
Researcher at Erasmus University Rotterdam
Publications - 273
Citations - 39450
Jaap W. Deckers is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 68, co-authored 268 publications receiving 37766 citations. Previous affiliations of Jaap W. Deckers include European Society of Cardiology & Hannover Medical School.
Papers
More filters
Journal ArticleDOI
Consistency of heart rate–QTc prolongation consistency and sudden cardiac death: The Rotterdam Study
Maartje N. Niemeijer,Marten E. van den Berg,Jaap W. Deckers,Oscar H. Franco,Albert Hofman,Jan A. Kors,Bruno H. Stricker,Peter R. Rijnbeek,Mark Eijgelsheim +8 more
TL;DR: The results suggest that repeated measurements of the QTc interval could enhance risk stratification, and persons with a consistently prolonged QTC interval did have a higher risk of SCD.
Journal ArticleDOI
Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease
Kim Fox,Michel E. Bertrand,Willem J. Remme,Roberto Ferrari,Maarten L. Simoons,Jaap W. Deckers +5 more
TL;DR: In this article, the effect of adding perindopril 8 mg once daily to standard preventive therapy in the subgroup of EUROPA patients with previous revascularization and without previous myocardial infarction (MI) was assessed.
Journal ArticleDOI
Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.
Dirk De Bacquer,Delphine De Smedt,Kornelia Kotseva,Kornelia Kotseva,Catriona Jennings,David R. Wood,Lars Rydén,Viveca Gyberg,Bahira Shahim,Philippe Amouyel,Jan Bruthans,Almudena Castro Conde,Renata Cifkova,Jaap W. Deckers,Johan De Sutter,Mirza Dilic,Maryna Dolzhenko,Andrejs Erglis,Zlatko Fras,Dan Gaita,Nina Gotcheva,John A. Goudevenos,Peter U. Heuschmann,Aleksandras Laucevičius,Seppo Lehto,Dragan Lovic,Davor Miličić,David D. Moore,Evagoras Nicolaides,Raphael Oganov,Andrzej Pajak,Nana Pogosova,Zeljko Reiner,Martin Stagmo,Stefan Störk,Lale Tokgozoglu,Dusko Vulic,Martin Wagner,Guy De Backer +38 more
TL;DR: In patients with stabilized CHD, comorbid conditions that may reflect the ubiquitous nature of atherosclerosis, dominate lifestyle-related and other modifiable risk factors in terms of prognosis, at least over a 2-year follow-up period.
Journal ArticleDOI
Progression and regression of the atherosclerotic plaque
TL;DR: Angiographic trials demonstrated that retardation or arrest of coronary atherosclerosis was possible after an intervention, but the ultimate goal, regression of the lesion, was only achieved in a small number of patients, which is a considerable achievement for those patients with coronary Atherosclerosis.
Journal ArticleDOI
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study
Claudio Ceconi,Kim Fox,W. J. Remme,Maarten L. Simoons,Jaap W. Deckers,Michel E. Bertrand,Giovanni Parrinello,Cornelius Kluft,Andrew D. Blann,Dennis V. Cokkinos,Roberto Ferrari +10 more
TL;DR: The PERTINENT trial observed significant effects of ACE inhibition on biomarkers of the atherothrombotic complications (D-dimer) and the proinflammatory cytokine TNF-alpha, but not on biomarker of inflammation associated with atherosclerosis (CRP and fibrinogen).